Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients
Recruiting now
Conditions studied: Asplenia
In brief
Spleen could have been surgically removed for trauma, cancer, auto-immune disease, or to perform a diagnosis. Spleen could be non-functional due to radiotherapy or splenic artery embolism. These patients are at risks of infectious diseases due to encapsulated bacteria, cancer, and thromboembolism disease. The purpose of this study is to assess complications occurring in French patients without spleen and to implement new diagnostic tools for follow-up.
Key facts
- Study ID
- NCT04199403
- Run by
- Poitiers University Hospital
- People needed
- 6000
- Starts
- 2020-01-09
- Expected to finish
- 2040-01-01
- Last updated by the study team
- 2026-07-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥18 year-old
- With asplenia due to splenectomy, splenic artery embolization or radiotherapy
You may not qualify if…
- Genetic asplenia including sick cell disease
Where it is running
- C.H. de Valenciennes — Valenciennes, France (enrolling)
- C.H. Victor Dupouy — Argenteuil, France (enrolling)
- C.H.U. de Toulouse — Toulouse, France (enrolling)
- C.H. de Tourcoing — Tourcoing, France (enrolling)
- C.H. d'Angoulême — Angoulême, France (enrolling)
- C.H.U. de Lille — Lille, France (enrolling)
- C.H.U. de Montpellier — Montpellier, France (enrolling)
- Hôtel-Dieu - CHU de Nantes — Nantes, France (enrolling)
- C.H.U. de Poitiers — Poitiers, France (enrolling)
- C.H. de Béthune — Béthune, France
- Hôpitaux de Chartres — Chartres, France
- C.H.U. de Rouen — Rouen, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.